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ABSTRACT
Primary antibody deficiencies (PADs) are a heterogeneous group of disorders, characterized by 
hypogammaglobulinemia and increased susceptibility to bacterial infections, leading to hos-
pitalizations. This study was performed to determine the main infectious causes of hospital 
admissions in selective Iranian patients with PADs. Forty patients with PADs, who were admit-
ted to the Infectious Ward of Children’s Medical Center Hospital during a 14-year period, were 
reviewed in this study. There were 115 documented episodes of hospital admission during a 
14-year period. The average length of hospital stay was 33.30 ± 25.72 days. Pneumonia was the 
most prominent infection leading to hospitalization among these patients (n = 48), followed 
by gastroenteritis (n = 23). Other less frequent causes of hospitalization were fever and neutro-
penia, septic arthritis, encephalitis, orbital cellulitis, sepsis, urinary tract infection, meningitis, 
oral ulcer, and lung abscess. The most common causative organisms of diarrhea were: Giardia 
lamblia, followed by Candida albicans, and Salmonella sp. Many patients with PADs suffer from 
repeated infections leading to hospitalization, in spite of immunoglobulin replacement therapy. 
Respiratory tract infections were the prominent cause of hospitalization among studied pa-
tients, followed by gastrointestinal infections.
Keywords: infection, hospitalization, primary antibody defi ciencies.
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INTRODUCTION
Primary antibody defi ciencies (PADs) are a het-
erogeneous group of disorders that range from 
a severe reduction of all serum immunoglobu-
lin isotypes with absent B cells to selective an-
tibody defi ciency with normal serum immu-
noglobulins. PADs consist of more than half of 
all primary immunodefi ciency diseases.1-3 The 
predominant symptomatic forms of PADs are 
common variable immunodefi ciency (CVID), 
X-linked agammaglobulinemia (XLA), and 
Hyper IgM syndromes (HIGM).1-4
Hypogammaglobulinemia, the major de-
fect in these diseases, leads to increased suscep-
tibility to bacterial infections, especially in the 
respiratory and gastrointestinal tracts.5-9
Recurrent infections and related compli-
cations could require hospitalizations. Immu-
noglobulin replacement therapy is the treat-
ment of choice, as it reduces episodes and 
severity of infection and improves quality of 
life; however, hospitalization due to infectious 
complications may occur either before or after 
treatment.10-14 
There are few studies dealing with the 
clinical manifestations and complications of 
patients with PADs. This retrospective study 
was performed to determine the main infec-
tious causes of hospital admissions, to obviate 
complications, and to help implementation of 
faster and fuller treatment.
PATIENTS AND METHODS
Study design
Medical records of 40 selective patients with 
PADs, who were admitted to the Infectious 
Ward of the Children’s Medical Center Hospi-
tal during a 14-year period (1994-2008), were 
reviewed in this study. All patients were under 
regular intravenous immunoglobulin therapy 
(400-500 mg/kg) every 3-4 weeks.
The Children’s Medical Center Hospital is 
the main referral center for primary immuno-
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defi ciency diseases in Iran. This study was reviewed and ap-
proved by the Ethics Committee of the Faculty of Medicine 
in Tehran University of Medical Sciences.
Inclusion and exclusion criteria
Patients were diagnosed on the grounds of standard criteria, 
introduced by the European Society for Immunodefi ciencies 
(ESID) and the Pan-American Group for Immunodefi ciency 
(PAGID).15 XLA is an agammaglobulinemia disease in male 
patients with reduced number of B cells (< 1%), which is 
caused by mutations in bruton tyrosin kinase (BTK) gene.8 
CVID is a heterogeneous group of disorders, characterized 
by hypogammaglobulinemia, variable number of B cells 
(> 2%), and exclusion of other well-known single gene defects.1 
HIGM is characterized by reduced serum levels of IgG and IgA 
and normal or elevated IgM level, resulting from mutations in 
different genes including CD40 ligand, CD40, activation in-
duced cytidine deaminase (AID), and Uracil g (UNG).16,17
Statistical analysis
SPSS statistical software package (version 14.0) was used for 
data analysis. p-value of less than 0.05 was considered sig-
nifi cant.
RESULTS
Characteristics of patients
In this study, medical records of 40 PADs patients (27 
male and 13 female) aged between 9 months and 16 
years (median: 6, mean: 6.98 ± 4.0 years) were reviewed. 
These included 26 patients with CVID, seven patients 
with XLA, and seven patients with HIGM (Table 1). 
During hospitalization, nine patients died due to infec-
tion.
Hospitalization episodes and length of stay
There were 115 documented episodes of hospital admis-
sion during the 14-year period. Seventy-two of them oc-
curred in CVID patients, while 26 and 17 in XLA and 
HIGM patients, respectively. On average, a patient was 
hospitalized for 33.30 ± 25.72 days (median: 29, range: 
2-109 days); XLA patients had a longer mean length of 
stay (51.57 ± 38.90 days) compared to HIGM patients 
(21.43 ± 14.89 days) and CVID patients (31.58 ± 21.90 
days). However, these differencee were not statistically 
significant (p-value = 0.073) (Figure 1).
 
Table 1. Characteristics of studied patients
  Total CVID XLA HIGM
Characteristic        
 Number of cases 40 26 7 7
 Sex (male/female) 27/13 15/11 7/- 5/2
 Age at the time of last admission  6.99 ± 4.01 6.87 ± 4.15 6.86 ± 4.95 7.57 ± 2.76
 (mean ± SD) years 
Serum Ig level (mg/dL)        
 IgG [median (range)] 235 (0 - 740) 292 (0 - 740) 100 (18 - 530) 230 (5 - 460)
 IgA [median (range)] 15 (0 - 220) 15 (0 - 220) 20 (0 - 20) 10 (5 - 45)
 IgM [median (range)] 28.5 (0 - 1400) 25 (0 - 230) 12.5 (1.6 - 27) 480 (75 - 1400)
Surface CD marker (absolute count)        
 CD19+ B-cell [median (range)] 156.2 176.4 11.5 358.3
  (0 - 1784.3) (12.3 - 1784.3) (0 - 47.8) (136.3 - 1258.9)
 CD3+ T-cell [median (range)] 1999.2  1767.8 3259.2 2151.8
  (162.0 - 6210.8) (196.9 - 5037.7) (162.0 - 5426.2) (1066.1 - 6210.8)
 CD4+ T-cell [median (range)] 845.5 575.8 1563.1 986.5
  (43.2 - 3776.8) (79.3 - 2898.4) (43.2 - 3014.2) (495.9 - 3776.8)
 CD8+ T-cell [median (range)] 971.7 885.0 1307.9 1289.3
  (140.4 - 4765.8) (241.2 - 4765.8) (140.4 - 2966.7) (307.6 - 2014.3)
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Causes of hospitalization
Pneumonia was the most prevailing infection leading to 
hospitalization among these patients (n = 48), followed 
by gastroenteritis (n = 23). Figure 2 shows seasonal dis-
tribution of these two predominant infections.
Sixteen out of 26 CVID patients were admitted at 
least once (61.5%) due to pneumonia, but one CVID 
patient was admitted four times. Four out of seven XLA 
patients were hospitalized at least once (57%) due to 
pneumonia, with one such patient being admitted eight 
times. Four out of seven HIGM patients were hospital-
ized (57%) with pneumonia, but one patient had three 
admissions.
Other less frequent causes of hospitalization were fe-
ver and neutropenia, septic arthritis, encephalitis, orbit-
al cellulitis, sepsis, urinary tract infection, meningitis, 
oral ulcer, and lung abscess (Table 2).
Figure 1: Mean duration of hospitalization among 
immunodeficient patients (p-value = 0.073).
Figure 2: Seasonal distributions of pneumonia and 
gastroenteritis leading to hospitalization.
Table 2. Complications leading to hospitalization
  Total CVID XLA HIGM
Pneumonia 49 31 11 7
Gastroenteritis 22 20 1 1
Fever and neutropenia 6 3 2 1
Septic arthritis 4 2 2 -
Aseptic arthritis 3 1 - 2
Urinary tract infection 2 2 - -
Meningitis 2 - 2 -
Fever 5 4 1 -
Cellulitis 3 - 1 2
Lung abscess 2 - 2 -
Sepsis 4 3 - 1
Hepatitis 1 1 - -
Encephalitis 3 - - 3
Skin infection 1 - 1 -
Pneumonia + gastroentritis 2 2 - -
Oral ulcer 2 - 2 -
Parotid abcess 1 1 - -
Purulent adenitis 1 1 - -
Peritonitis 1 1 - -
Hepatic failure 1 1 - -
Total admissions 115 73 25 17
Associated features
Prevalence of consanguineous marriages was of 47.5% 
among patients’ parents. Also a history of death due to in-
fection in siblings of the affected patient was found in 11 
families. Four patients had a positive family history of im-
munodefi ciency. Thirty patients (75%) had a history of 
recurrent otitis media (20 CVID, 4 XLA, 3 HIGM), 25 pa-
tients (62.5%) had sinusitis. Seven patients developed bron-
chiectasis. Lymphocytic interstitial pneumonia was found 
in one patient. Recurrent diarrhea occurred in 17 patients 
(42.5 %), while one patient had inﬂ ammatory bowel disease 
(ulcerative colitis). One subject had Hirschsprung disease. 
Eleven patients underwent upper endoscopy, and the most 
common fi ndings were: duodenitis (seven cases), esophagi-
tis (four cases), gastritis (four cases), and villous atrophy (six 
patients). One CVID patient developed Hodgkin’s disease, 
while autoimmune diseases were detected in three CVID 
cases; one had idiopathic thrombocytopenic purpura and 
two had hemolytic anemia.
Microorganisms
Microbiological cultures were performed in some patients 
before empiric therapy. The most common causative organ-
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isms of diarrhea were: Giardia lamblia (n = 9), followed by 
Candida albicans (n = 4), and Salmonella sp. (n = 3). Shig-
ella fl exneri was the causative organism in one patient, and 
Cryptosporidium parvum in another case. In four patients, 
the etiologic pathogen of the diarrhea was not isolated. 
Urine culture of patients hospitalized due to urinary tract 
infection was positive for E. coli. Blood cultures were taken 
in 66 episodes of infections, but turned out positive in only 
9% (n = 6). Pseudomonas sp. was detected in four cases, and 
Pneumococcus and Acinetobacter in two cases. Bone marrow 
culture performed in four episodes grew acid fast bacilli in 
one case.
DISCUSSION
Primary antibody defi ciencies are a heterogeneous group 
of rare disorders, characterized by decreased serum levels 
of immunoglobulin isotypes and increased susceptibility 
to bacterial infections, especially in the respiratory and gas-
trointestinal tracts.2,3,18 Despite immunoglobulin replace-
ment therapy, many patients still suffer from repeated infec-
tions leading to recurrent hospitalization. 
This study demonstrated the frequency and the main 
causes of hospital admission among Iranian PADs. Respira-
tory tract infec tions were the prominent cause of hospitali-
zation among studied patients, followed by gastrointestinal 
infections. Approximately 60% of CVID, XLA, and HIGM 
patients were admitted at least once due to pneumonia. Pre-
vious reports on PADs patients revealed that lower respira-
tory tract infections were the most common manifestation 
in this group of patients. In a previous study on 248 patients 
with CVID, the majority of patients had at least one episode 
of pneumonia (78%) prior to their diagnosis.6 A study re-
viewing records from 201 XLA patients in the United States, 
reported pneumonia in 62% of subjects.7 Another study on 
79 patients with HIGM syndrome reported 81% with at 
least one episode of pneumonia.19 
The second most frequently affected organ system in our 
study was the gastrointestinal tract comprising almost 20% of 
all hospital admissions. In other studies, gastrointestinal dis-
orders were reported from 20-47% of patients with PADs.6,20,21 
Recurrent diarrhea occurred in 42.5% of the patients. Other 
studies reported that chronic diarrhea of unspecifi ed cause 
occured commonly in PADs, with frequencies ranging from 
40% to 60%.22-24 The diarrhea is often infectious. Giardia lam-
blia was the most common organism among patients with 
diarrhea. Other common causative organisms for diarrhea 
were Candida and Salmonella spp.; other studies showed that 
the most frequently identifi ed organisms causing infectious 
diarrhea were Giardia lamblia, Campylobacter sp., and Salmo-
nella sp.6,7,25 Although Crypotosporidium parvum is a common 
pathogen among HIGM patients,19 it was found in only one 
patient in our study, which could be due to the small number 
of these patients in the current series. 
PADs are the conditions that make patients prone to a 
variety of complications, some made worse by delayed di-
agnosis and insuffi cient treatment. Despite immunoglobu-
lin replacement therapy and current management plans, 
patients remain at risk of outbreaks of bacterial infections. 
The delay in diagnosis and treatment of patients often en-
tails complications that are more pronounced, which may 
be widespread and cause negative effects on both morbidity 
and mortality.
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